RTI Biologics and Zimmer Dental Enter Distribution Agreement for Global Dental Biologic Implants

RTI Biologics Inc. (RTI) RTIX, a leading provider of orthopedic and other biologic implants, announced today the signing of an exclusive, 10-year distribution agreement with Zimmer Dental Inc. for biologic implants for the dental market worldwide. Under the new agreement, which is effective Sept. 30, 2010, RTI will supply sterilized allograft and xenograft implants for an agreed upon transfer fee, as opposed to the marketing fee structure of the companies’ previous agreement. Zimmer will be responsible for worldwide marketing and distribution of the biologic implants for use in dental applications.